These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6732994)

  • 21. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of amiodarone on electric induction, morphology, and rate of ventricular tachycardia and its relation to clinical efficacy.
    Reddy CP; Kuo CS; Jivrajka V
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):1055-62. PubMed ID: 6209624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
    Rasmussen V; Berning J
    Acta Med Scand; 1979; 205(1-2):31-7. PubMed ID: 367085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of phenytoin on refractoriness and conduction in the human heart.
    Dhatt MS; Gomes JA; Reddy CP; Akhtar M; Caracta AR; Lau SH; Damato AN
    J Cardiovasc Pharmacol; 1979; 1(1):3-18. PubMed ID: 94379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 26. Study of the temporal effects on conduction and refractoriness of the His-Purkinje system in man.
    Reddy CP; Damato AN; Akhtar M; Dhatt MS; Gomes JA; Foster JR
    Am Heart J; 1978 Sep; 96(3):316-25. PubMed ID: 685805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Electrophysiologic properties of acebutolol in man].
    Touboul P; Huerta F; Porte J; Delahaye JP
    Therapie; 1975; 30(3):417-27. PubMed ID: 1224363
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction.
    Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M
    J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavior of postextrasystolic His-Purkinje system refractoriness after multiple premature beats.
    Tchou P; Lehmann MH; Mahmud R; Dongas J; Denker S; Akhtar M
    J Lab Clin Med; 1988 Apr; 111(4):405-15. PubMed ID: 2450937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
    Touboul P; Porte J; Huerta F; Delahaye JP
    Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of ajmaline and amiodarone on the heart conduction system].
    Pleskot M; Tilser P; Pidrman V
    Vnitr Lek; 1986 Feb; 32(2):165-72. PubMed ID: 3962197
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of the electrophysiological effects of amiodarone using simultaneous recordings of monophasic and bundle-of-his action potentials].
    Cabasson J; Puech P; Mellet JM; Guimond C; Bachy C; Sassine A
    Arch Mal Coeur Vaiss; 1976 Jul; 69(7):691-9. PubMed ID: 821440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of intravenous disopyramide phosphate on the Wolff-Parkinson-White syndrome.
    Tajima T; Dohi Y
    Pacing Clin Electrophysiol; 1982 Sep; 5(5):741-7. PubMed ID: 6182545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of refractoriness of the human Purkinje system.
    Fleischmann DW; Pop T
    Cardiovasc Res; 1978 Nov; 12(11):681-91. PubMed ID: 750081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sudden rate acceleration on the human His-Purkinje system: adaptation of refractoriness in a dampened oscillatory pattern.
    Tchou PJ; Lehmann MH; Dongas J; Mahmud R; Denker ST; Akhtar M
    Circulation; 1986 May; 73(5):920-9. PubMed ID: 3698237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological effects of mexiletine in man.
    Roos JC; Paalman AC; Dunning AJ
    Br Heart J; 1976 Dec; 38(12):1262-71. PubMed ID: 1008969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent electrophysiologic effects of amiodarone in the immature canine heart.
    Pickoff AS; Singh S; Flinn CJ; Torres E; Ezrin AM; Gelband H
    Am J Cardiol; 1983 Sep; 52(5):621-5. PubMed ID: 6613889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitation of the atrial extrastimulus technique for assessment of the His-Purkinje system in patients with right bundle branch block.
    Wyse DG; Szeto PM; Bond R
    Clin Invest Med; 1983; 6(4):275-9. PubMed ID: 6671357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.